CLOV vs ICCC
Clover Health Investments Corp (CLOV) versus ImmuCell Corporation (ICCC) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported ICCC revenue for 2024-12-31 was $26.5M. Net income was -$2.2M. Revenue was up 51.6% from 2023-12-31 to 2024-12-31. ICCC currently screens at market cap $58.9M.
CLOV currently screens at market cap $1.55B. ICCC currently screens at market cap $58.9M.
Not investment advice. Open the CLOV and ICCC stock pages for the full models.
Not investment advice.